Permanently Discontinued

NAPROXEN SODIUM TABLETS

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is NAPROXEN SODIUM TABLETS discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that NAPROXEN SODIUM TABLETS 220MG has been permanently discontinued (last updated January 4, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is NAPROXEN SODIUM TABLETS not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength220MG

Last updated2019-01-04

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NAPROXEN SODIUM TABLETS

VITA HEALTH PRODUCTS INC

220MG · DIN 02378876

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MOTRIMAX 12 HOUR TABLETS

MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC

220MG · DIN 02423790

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

NAPROXEN

PHARMASCIENCE INC

220MG · DIN 02362430

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ALEVE CAPLETS

BAYER INC

220MG · DIN 02301733

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

NAPROXEN LIQUID GELS

PHARMASCIENCE INC

220MG · DIN 02442922

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MAXIDOL LIQUID GELS

BAYER INC

220MG · DIN 02372991

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02385007

Strength

220MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

NAPROXEN SODIUM

Tier

Unrated

Last Updated

2019-01-04

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244